tiprankstipranks
Trending News
More News >
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
US Market

Chemomab Therapeutics (CMMB) Technical Analysis

Compare
256 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Chemomab Therapeutics’s (CMMB) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Chemomab Therapeutics is a Buy.
Chemomab Therapeutics’s (CMMB) 20-Day exponential moving average is 1.31, while Chemomab Therapeutics’s (CMMB) share price is $1.2, making it a Sell.
Chemomab Therapeutics’s (CMMB) 50-Day exponential moving average is 1.32, while Chemomab Therapeutics’s (CMMB) share price is $1.2, making it a Sell.

Chemomab Therapeutics (CMMB) Pivot Points

Jun 12, 2025, 11:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.17
1.21
1.26
1.30
1.35
1.39
1.44
Fibonacci
1.21
1.25
1.27
1.30
1.34
1.36
1.39
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Chemomab Therapeutics (CMMB) Moving Averages

Jun 12, 2025, 11:17 PM
Period
Simple
Exponential
MA5
1.29Sell
1.28Sell
MA10
1.32Sell
1.30Sell
MA20
1.33Sell
1.31Sell
MA50
1.25Sell
1.32Sell
MA100
1.46Sell
1.39Sell
MA200
1.58Sell
1.43Sell
Chemomab Therapeutics’s (CMMB) 10-Day exponential moving average is 1.30, while Chemomab Therapeutics’s (CMMB) share price is $1.2, making it a Sell.
Chemomab Therapeutics’s (CMMB) 100-Day exponential moving average is 1.39, while Chemomab Therapeutics’s (CMMB) share price is $1.2, making it a Sell.
Chemomab Therapeutics’s (CMMB) stock price is $1.2 and Chemomab Therapeutics’s (CMMB) 50-day simple moving average is 1.25, creating a Sell signal.
Chemomab Therapeutics’s (CMMB) stock price is $1.2 and Chemomab Therapeutics’s (CMMB) 100-day simple moving average is 1.46, creating a Sell signal.
Chemomab Therapeutics’s (CMMB) stock price is $1.2 and Chemomab Therapeutics’s (CMMB) 200-day simple moving average is 1.58, creating a Sell signal.

Chemomab Therapeutics (CMMB) Technical Indicators

Jun 12, 2025, 11:17 PM
Name
Value
Implied Action
RSI (14)
36.37
Neutral
STOCH (9,6)
31.56
Neutral
STOCHRSI (14)
25.35
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
14.26
Buy
Williams %R
-100.00
Buy
CCI (14)
-161.65
Buy
ATR (14)
0.09
-
Ultimate Oscillator
47.76
Neutral
ROC
-13.04
Sell
Chemomab Therapeutics’s (CMMB) Relative Strength Index (RSI) is 36.37, creating a Neutral signal.
Chemomab Therapeutics’s (CMMB) Trend Strength Indicator (ADX) is 14.26, creating a Buy signal.
Chemomab Therapeutics’s (CMMB) Commodity Channel Index (CCI) is -161.65, creating a Buy signal.
Chemomab Therapeutics’s (CMMB) Price Rate of Change (ROC) is -13.04, creating a Sell signal.

FAQ

Is CMMB a Buy, Hold, or Sell?
Based on CMMB’s technical indicators, CMMB is a Sell.
    What is CMMB’s RSI (14)?
    CMMB’s RSI (14) is 36.37, which suggests CMMB is a Neutral.
      What is CMMB’s MACD?
      CMMB’s MACD is >-0.01, which suggests CMMB is a Buy.
        What is CMMB’s 5-day moving average?
        CMMB’s 5-day moving average is 1.29, which suggests CMMB is a Sell.
          What is CMMB’s 20-day moving average?
          CMMB 20-day moving average is 1.33, which suggests CMMB is a Sell.
            What is CMMB’s 50-day moving average?
            CMMB’s 50-day moving average is 1.25, which suggests CMMB is a Sell.
              What is CMMB’s 200-day moving average?
              CMMB’s 200-day moving average is 1.58, which suggests CMMB is a Sell.
                What is CMMB’s Williams % R (14)?
                CMMB’s Williams % R (14) is -100.00, which suggests CMMB is a Buy.
                  What is CMMB’s CCI (14)?
                  CMMB’s CCI (14) is -161.65, which suggests CMMB is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis